Intrinsic Value

IOB price has not been updated for more than 5 years. This may indicate that the stock has been delisted.

The intrinsic value of Ion Beam Applications SA (IOB) under the Base Case is 17.97 EUR per share. Compared with the current market price of 16.2 EUR, the stock appears Undervalued by 10% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

IOB Intrinsic Value
€17.97
Undervaluation 10%
Intrinsic Value
Price €16.2
Alert me when IOB is below its intrinsic value
Today €14.38 · 11.3% below the current price

We don’t have enough historical valuation data to make this comparison.

Alternatives to IOB

Fundamental Analysis

What Ion Beam Applications Does

Health Care

Ion Beam Applications, or IBA, builds and services particle accelerator systems, best known for proton therapy equipment used to treat cancer. The company also makes industrial accelerators used in applications such as sterilizing medical products, inspecting materials, and other precision radiation processes. In simple terms, IBA sells the complex machines and the technical support needed to install, run, and maintain them.

Headquarters
Belgium BE
Employees
2 039
IPO date
Jun 13, 1998
Read the full company overview
View Company Overview

Ion Beam Applications has no economic moat

No Moat Narrow Wide

Ion Beam Applications SA lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.

Read the full moat analysis
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue IOB Research

Decided on Ion Beam Applications? Get an email when IOB reaches the price you’d buy at. Free with an account.

Other Ion Beam Applications listings

What is the Intrinsic Value of one IOB stock?

The intrinsic value for Ion Beam Applications SA (IOB) under the Base Case is 17.97 EUR.

Is IOB stock undervalued or overvalued?

Compared with the current market price of 16.2 EUR, the stock appears Undervalued by 10% .

How reliable are our estimates? See how past valuations played out
Back to Top